FindTrial
Sign In

Role of dose of ecosprin in high risk pregnant individuals

Role of ecosprin dose in high risk gestosis score pregnancy individuals

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036125
Enrollment
60
Registered
2021-09-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O140- Mild to moderate pre-eclampsia

Interventions

Control Intervention1: Tab.Ecosprin 150 mg AND tab ecosprin 75mg: 60 High risk gestosis score individuals in which 30 members will be supplemented with 75mg ecosprin 30 members will be supplemented

Sponsors

Shaik Sameera
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: .High risk gestosis score pregnancy individuals (score of greater than or equal to 3) 2.Family history of pre-eclampsia 3.History of pre-eclampsia in past pregnancies 4.Antiphospholipid syndrome 5.Chronic renal diseases 6.Hypertension 7.Diabetes 8.Conceived with Artificial reproductive techniques.

Exclusion criteria

Exclusion criteria: 1.Low risk gestosis score individuals 2.Individuals in whom ecosprin is contra indicated 3.Bleeding disorders and clotting disorders 4.Severe astma

Design outcomes

Primary

MeasureTime frame
assess symptoms of pre eclampsia with 75mg and 150 mg ecosprinTimepoint: 24MONTHS—

Secondary

MeasureTime frame
symptoms of pre eclampsia in high risk gestosis score pregnancy individuals.Timepoint: 24MONTHS—

Countries

India

Contacts

Public ContactShaikSameera

Dr.PINNAMANENI SIDDHARTHA INSTITUTE OF MEDICAL SCINCES AND RESEARCH FOUNDATION

sajanagogineni@gmail.com8790524945

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026